The Evidence Has to Travel

A medical manufacturer can have an excellent product and still make its commercial team hunt through six different versions of the truth.

The engineer knows why the material changed. The clinician knows what matters in practice. The product manager has the current specification. The educator has seen where users get confused. Marketing has last year’s brochure. Sales has a deck containing one claim nobody can quite source.

There is no shortage of knowledge. It just does not travel well.

I noticed this while looking at small technical companies whose products have to earn trust from several audiences at once. The details varied—clinical evidence, product performance, teaching use, funding rules, user support—but the commercial problem kept the same shape.

Specialist knowledge had to cross a border.

On one side were the people who understood the product deeply. On the other were buyers, partners, educators, patients, procurement teams, distributors, and salespeople who needed an answer they could use without sitting through the entire history of the field.

The usual language for solving this is strangely weak. “Content support.” “AI enablement.” “Knowledge management.” Each phrase sounds like a service category searching for a problem.

The actual job is easier to recognize:

Make the evidence findable. Keep its source attached. Translate it for the next audience without sanding away the technical truth.

That last part is where the work becomes difficult.

Flattening is fast. Remove the caveats, swap the mechanism for a benefit, and turn every uncertain result into a confident bullet. The copy becomes easier to read and harder to trust.

Refusing to translate is not better. A folder of papers, specifications, training notes, and expert interviews may be accurate while remaining commercially inert. “It is all in there” is not a useful answer to someone preparing for a customer call in twenty minutes.

Good evidence translation sits between those failures. It knows which detail can be shortened, which qualification must survive, and which claim needs a visible trail back to source. It produces something a non-specialist can carry into the next conversation without pretending they have become the specialist.

This is not only a writing problem. It is a movement problem.

Can a useful observation from a trainer reach product marketing? Can a clinical claim in a presentation be traced to the evidence behind it? Can sales find the current answer instead of reusing the nearest answer? Can a customer question travel back to the expert who should sharpen the explanation?

Technical companies often describe trust as something created by expertise. That is only half of it. Expertise trapped in one department does not create much trust outside that department.

The evidence has to travel.